Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers (Q33381378)

26 July 2017

title

Phase I study of epigenetic modulation with 5-azacytidine and valproic acid in patients with advanced cancers (English)

1 reference

26 July 2017

Razelle Kurzrock

1 reference

26 July 2017

Guillermo Garcia-Manero

object named as

Guillermo Garcia-Manero

1 reference

26 July 2017

Fadi Braiteh

1 reference

26 July 2017

Andres O Soriano

1 reference

26 July 2017

David Hong

1 reference

26 July 2017

Marcella M Johnson

1 reference

26 July 2017

Leandro De Padua Silva

1 reference

26 July 2017

Hui Yang

1 reference

26 July 2017

Stefanie Alexander

1 reference

26 July 2017

Johannes Wolff

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

26 July 2017

published in

Clinical Cancer Research

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

6296-6301

1 reference

Epigenetic changes in solid and hematopoietic tumors.

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Antileukemia activity of the combination of 5-aza-2'-deoxycytidine with valproic acid

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Gene silencing in cancer in association with promoter hypermethylation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Valproate: past, present, and future.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

DNA methyltransferase inhibitors-state of the art.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Review of the clinical experience with 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Histone deacetylases and cancer: causes and therapies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2582814

10.1158/1078-0432.CCR-08-1247

21 June 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference

26 July 2017

1 reference